Pharmaids Pharmaceuticals Limited (BOM:524572)

Pharmaids Pharmaceuticals Statistics

Total Valuation

BOM:524572 has a market cap or net worth of INR 1.50 billion. The enterprise value is 1.69 billion.

Market Cap	1.50B
Enterprise Value	1.69B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:524572 has 35.27 million shares outstanding. The number of shares has increased by 38.67% in one year.

Current Share Class	35.27M
Shares Outstanding	35.27M
Shares Change (YoY)	+38.67%
Shares Change (QoQ)	+0.91%
Owned by Insiders (%)	68.23%
Owned by Institutions (%)	n/a
Float	6.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.04
PB Ratio	2.92
P/TBV Ratio	7.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.74
EV / Sales	6.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.84

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.39.

Current Ratio	0.81
Quick Ratio	0.30
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	-0.70
Interest Coverage	-5.36

Financial Efficiency

Return on equity (ROE) is -26.91% and return on invested capital (ROIC) is -24.20%.

Return on Equity (ROE)	-26.91%
Return on Assets (ROA)	-12.78%
Return on Invested Capital (ROIC)	-24.20%
Return on Capital Employed (ROCE)	-28.75%
Weighted Average Cost of Capital (WACC)	5.99%
Revenue Per Employee	8.86M
Profits Per Employee	-4.74M
Employee Count	28
Asset Turnover	0.26
Inventory Turnover	5.23

Taxes

Income Tax	-45.82M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.05% in the last 52 weeks. The beta is 0.11, so BOM:524572's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-44.05%
50-Day Moving Average	47.81
200-Day Moving Average	56.84
Relative Strength Index (RSI)	33.93
Average Volume (20 Days)	3,238

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524572 had revenue of INR 248.12 million and -132.67 million in losses. Loss per share was -3.52.

Revenue	248.12M
Gross Profit	81.47M
Operating Income	-197.32M
Pretax Income	-202.05M
Net Income	-132.67M
EBITDA	-175.33M
EBIT	-197.32M
Loss Per Share	-3.52

Balance Sheet

The company has 2.39 million in cash and 201.32 million in debt, with a net cash position of -198.93 million or -5.64 per share.

Cash & Cash Equivalents	2.39M
Total Debt	201.32M
Net Cash	-198.93M
Net Cash Per Share	-5.64
Equity (Book Value)	513.11M
Book Value Per Share	14.65
Working Capital	-56.40M

Cash Flow

In the last 12 months, operating cash flow was -180.89 million and capital expenditures -108.35 million, giving a free cash flow of -289.24 million.

Operating Cash Flow	-180.89M
Capital Expenditures	-108.35M
Free Cash Flow	-289.24M
FCF Per Share	-8.20

Margins

Gross margin is 32.84%, with operating and profit margins of -79.52% and -53.47%.

Gross Margin	32.84%
Operating Margin	-79.52%
Pretax Margin	-81.43%
Profit Margin	-53.47%
EBITDA Margin	-70.66%
EBIT Margin	-79.52%
FCF Margin	n/a

Dividends & Yields

BOM:524572 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.67%
Shareholder Yield	-38.67%
Earnings Yield	-8.86%
FCF Yield	-19.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2